These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 8925545
1. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma]. Spicka I, Haber J, Petruzelka L, Kolesková E, Sálková J, Straub J, Zounar R, Klener P. Cas Lek Cesk; 1996 Jul 14; 135(14):450-3. PubMed ID: 8925545 [Abstract] [Full Text] [Related]
2. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma]. Haber J, Spicka I, Petruzelka L, Kolesková E, Straub J, Jonásová A, Pospísilová B. Vnitr Lek; 1996 Apr 14; 42(4):262-7. PubMed ID: 8693713 [Abstract] [Full Text] [Related]
4. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP, Abels RI, McNeill MV, Sullivan DJ. Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662 [Abstract] [Full Text] [Related]
5. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Henry DH, Brooks BJ, Case DC, Fishkin E, Jacobson R, Keller AM, Kugler J, Moore J, Silver RT, Storniolo AM, Abels RI, Gordon DS, Nelson R, Larholt K, Bryant E, Rudnick S. Cancer J Sci Am; 1995 Dec 13; 1(4):252-60. PubMed ID: 9166485 [Abstract] [Full Text] [Related]
6. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response]. León Molinari P, Jiménez Monteagudo M, Barona Zamora P, Riol Diego M, Castro Paz L, Sierrasesúmaga Ariznavarreta L. An Esp Pediatr; 1998 Jul 13; 49(1):17-22. PubMed ID: 9718761 [Abstract] [Full Text] [Related]
9. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery. Braga M, Gianotti L, Gentilini O, Vignali A, Di Carlo V. Hepatogastroenterology; 1997 Jul 13; 44(15):685-90. PubMed ID: 9222672 [Abstract] [Full Text] [Related]
15. Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma. Katodritou E, Speletas M, Zervas K, Kapetanos D, Georgiou E, Christoforidou A, Pavlitou A, Sion M, Christakis J. Lab Hematol; 2006 Jul 13; 12(1):47-54. PubMed ID: 16513546 [Abstract] [Full Text] [Related]
17. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer]. Bösze P, Mayer A, Thurzó L, Kiss A, Rák K, Stumpf J. Orv Hetil; 1995 Nov 19; 136(47):2567-72. PubMed ID: 8532322 [Abstract] [Full Text] [Related]
18. Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin. Dunphy FR, Dunleavy TL, Harrison BR, Boyd JH, Varvares MA, Dunphy CH, Rodriguez JJ, McDonough EM, Minster JR, McGrady MD. Cancer; 1997 Apr 15; 79(8):1623-8. PubMed ID: 9118049 [Abstract] [Full Text] [Related]
19. Anemia in multiple myeloma. Ludwig H, Pohl G, Osterborg A. Clin Adv Hematol Oncol; 2004 Apr 15; 2(4):233-41. PubMed ID: 16163188 [Abstract] [Full Text] [Related]